Table 4.
Systematic review of retrospective studies of CHVI from liver trauma.
| First author | Year | Number of liver trauma | Number of CHVI | Incidence | Age – Sex | Type of injury | Type of CHVI | Interval between trauma – CHVI (d) | Size (mm) | Treatment | Survival |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Our study | 2023 | 318 | 27 | 8.5 | 34.6 – 21M/6F | 19 NP 8 Penetrating |
IHPA | 6.5 (0–31) | 12.3 (2.5–46) | 13 NIM 13 AE 1 Surgery |
1 death |
| Henry15 | 2022 | 450 | 7 | 1.6 | – | – | PA | 6 (0–16.9) | 9.5 (2–17) | 5 AE 2 Surgery |
Yes |
| Kagoura16 | 2022 | 176 | 3 AAST I-II 7 AAST III-V |
5.7 | – | – | PA | – | 4.5 AAST I–II 6.5 AAST III–V |
4 NIM – 4 thromboses 6 AE |
Yes |
| Lada17 | 2021 | 171 | 12 | 7.0 | PA - AVF | 1 death | |||||
| Wagner18 | 2020 | 634 | 18 AAST III-V | 2.8 | – | 12 NP 6 Penetrating |
PA | 6.5 (4–9) | – | 4 NIM – 4 thromboses 14 AE 2 Surgery |
2 death |
| Kittaka19 | 2015 | 62 | 7 | 11.3 | 6M/1F | – | PA | 5 (3–7) | 7.7 (2–11.9) | 6 NIM – 6 thromboses 1 AE |
Yes |
| Østerballe20 | 2014 | 259 | 7 | 2.7 | 30.4 – 5M/2F | 7 NP | IHPA | – | 7 AE | Yes | |
| Forlee21 | 2004 | – | 8 | 26 – 7M/1F | 1 NP 7 Penetrating |
IHPA | 15 (1-60) | – | 1 NIM 7 AE |
– | |
| Croce22 | 1994 | 482 | 2 AAST I-II 4 AAST III-V |
1.2 | 24 – 5M/1F | 3 NP 3 Penetrating |
IHPA | — | — | 6 Surgery | 2 death |
AE, angioembolization; AVF, arteriovenous fistula; d, days; IHPA, Intrahepatic pseudoaneurysm; NIM, noninterventional management; NP, nonpenetrating; PA, pseudoaneurysm.